Collegium Pharmaceutical, Inc. Incentive from Lessor
Collegium Pharmaceutical, Inc. (COLL) had Incentive from Lessor of $8.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes › Leases
us-gaap:IncentiveFromLessor · last filed 2018-03-07
- 2017-09-30: Incentive from Lessor $8.00K.
- 2017-06-30: Incentive from Lessor $17.00K.
- 2017-03-31: Incentive from Lessor $25.00K.
- 2016-12-31: Incentive from Lessor $34.00K.
| Period end | Incentive from Lessor |
|---|---|
| 2017-09-30 | $8.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $17.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $25.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $34.00K 10-K · filed 2018-03-07 |
| 2016-09-30 | $42.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $51.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $59.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $68.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $76.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $85.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $93.00K 10-Q/A · filed 2015-07-17 |
| 2014-12-31 | $101.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |